Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Anterix (ATEX) Shares Outstanding (2016 - 2025)

Historic Shares Outstanding for Anterix (ATEX) over the last 12 years, with Q4 2025 value amounting to $18.7 million.

  • Anterix's Shares Outstanding rose 76.94% to $18.7 million in Q4 2025 from the same period last year, while for Dec 2025 it was $18.7 million, marking a year-over-year increase of 76.94%. This contributed to the annual value of $18.6 million for FY2025, which is 86.71% up from last year.
  • Latest data reveals that Anterix reported Shares Outstanding of $18.7 million as of Q4 2025, which was up 76.94% from $18.7 million recorded in Q3 2025.
  • In the past 5 years, Anterix's Shares Outstanding registered a high of $19.0 million during Q2 2023, and its lowest value of $17.7 million during Q1 2021.
  • Its 5-year average for Shares Outstanding is $18.6 million, with a median of $18.6 million in 2024.
  • Its Shares Outstanding has fluctuated over the past 5 years, first skyrocketed by 513.93% in 2022, then tumbled by 247.86% in 2024.
  • Quarter analysis of 5 years shows Anterix's Shares Outstanding stood at $18.4 million in 2021, then grew by 2.74% to $18.9 million in 2022, then dropped by 1.67% to $18.6 million in 2023, then grew by 0.18% to $18.6 million in 2024, then increased by 0.77% to $18.7 million in 2025.
  • Its Shares Outstanding was $18.7 million in Q4 2025, compared to $18.7 million in Q3 2025 and $18.7 million in Q2 2025.